ADC Therapeutics SAADC Therapeutics SAADC Therapeutics SA

ADC Therapeutics SA

No trades
See on Supercharts
Market capitalization
‪390.88 M‬USD
−2.93USD
‪−240.05 M‬USD
‪69.56 M‬USD
‪55.62 M‬
Beta (1Y)
2.09

About ADC Therapeutics SA

CEO
Ameet Mallik
Headquarters
Epalinges
Employees (FY)
162
Founded
2011
ISIN
CH0499880968
FIGI
BBG00Q6Q3QX1
ADC Therapeutics SA is a clinical-stage biotechnology company. It engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ADCT is 4.72 USD — it has decreased by 0.84% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange ADC Therapeutics SA stocks are traded under the ticker ADCT.
ADC Therapeutics SA is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
ADCT stock is 6.96% volatile and has beta coefficient of 2.09. Check out the list of the most volatile stocks — is ADC Therapeutics SA there?
One year price forecast for ADC Therapeutics SA has a max estimate of 13.00 USD and a min estimate of 8.00 USD.
ADCT earnings for the last quarter are −0.58 USD per share, whereas the estimation was −0.63 USD resulting in a 8.52% surprise. The estimated earnings for the next quarter are −0.50 USD per share. See more details about ADC Therapeutics SA earnings.
ADC Therapeutics SA revenue for the last quarter amounts to ‪14.49 M‬ USD despite the estimated figure of ‪15.15 M‬ USD. In the next quarter revenue is expected to reach ‪15.31 M‬ USD.
Yes, you can track ADC Therapeutics SA financials in yearly and quarterly reports right on TradingView.
ADCT stock has risen by 0.21% compared to the previous week, the month change is a 1.51% rise, over the last year ADC Therapeutics SA has showed a 102.58% increase.
ADCT net income for the last quarter is ‪−85.03 M‬ USD, while the quarter before that showed ‪−47.81 M‬ USD of net income which accounts for −77.86% change. Track more ADC Therapeutics SA financial stats to get the full picture.
Today ADC Therapeutics SA has the market capitalization of ‪390.88 M‬, it has increased by 18.10% over the last week.
No, ADCT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ADCT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ADC Therapeutics SA stock right from TradingView charts — choose your broker and connect to your account.
ADCT reached its all-time high on Jul 2, 2020 with the price of 56.59 USD, and its all-time low was 0.36 USD and was reached on Nov 13, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 22, 2024, the company has 162.00 employees. See our rating of the largest employees — is ADC Therapeutics SA on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ADC Therapeutics SA technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ADC Therapeutics SA stock shows the buy signal. See more of ADC Therapeutics SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ADC Therapeutics SA future price: according to them, ADCT price has a max estimate of 13.00 USD and a min estimate of 8.00 USD. Read a more detailed ADC Therapeutics SA forecast: see what analysts think of ADC Therapeutics SA and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ADC Therapeutics SA EBITDA is ‪−163.83 M‬ USD, and current EBITDA margin is −231.62%. See more stats in ADC Therapeutics SA financial statements.